So BiDil appears to have failed - putting together 2 cheap generics into one expensive prescription pill just didn't prove to be a winner for NitroMed. And, Merck/Schering-Plough just took a very …
Behemoth Pharmaceutical Hires Notre Dame Coach as CEO
In a surprise move announced today, Behemoth Pharmaceutical has hired Charlie Weis, former Notre Dame football coach, to be CEO. "We needed some fresh leadership around here, and Charlie Weis, with …
Continue Reading about Behemoth Pharmaceutical Hires Notre Dame Coach as CEO →
Lypitorin now recommended for Post-Trans RILV Bypass HAM-d New England Syndrome
In yet another clinical study to show the unique efficacy of Lypitorin, Phizer-Plow has announced the the drug is now approved for use with Post-Transplant Random Ischemic Left Ventricle Bypass …
Doctors now to be Required to Consult with Patients
In a stunning move, the AMA Board of Directors has confirmed that it has changed its guidelines, now requiring doctors to consult with their patients before subscribing medicines, reversing the …
Continue Reading about Doctors now to be Required to Consult with Patients →
Hexubera promotion goes terribly wrong
What seemed, at first, to be a terrific marketing idea ended in disaster this week, when, in the dead of night, a life-sized Hexubera "bong" was installed to replace the Leaning Tower of Pisa. "We …
Continue Reading about Hexubera promotion goes terribly wrong →
Drug Reps to start leaving Disease Samples
In a creative new move to increase market share, Behemouth Pharmaceuticals has switched from the practice of having sales reps leave drug samples, instead having them leave samples of communicable …
Continue Reading about Drug Reps to start leaving Disease Samples →